The “Think D8” Principle

The “Think D8” is a mnemonic tool introduced in the WHO AWaRe Antibiotic Book. It is designed to be a mental checklist for healthcare providers to run through before prescribing any antibiotic. Its goal is to ensure a deliberate, rational, and safe approach to antibiotic use, thereby combating antimicrobial resistance (AMR) and protecting patients.

The “8 Ds” are:

1. Diagnose
2. Decide
3. Drug (Medicine)
4. Dose
5. Delivery
6. Duration
7. Discuss
8. Document

---

Detailed Breakdown of the 8 Ds with an Example

Let’s use a practical scenario to illustrate each step: A 35-year-old woman presents with a cough, sore throat, and mild fever for 3 days.

1. Diagnose – What is the clinical diagnosis?

• Action: Perform a clinical assessment. Look for signs and symptoms. Is there clear evidence of a bacterial infection?
• Example: On examination, the patient has a runny nose, a hoarse voice, and a mildly red throat. There is no tonsillar exudate, swollen lymph nodes, or difficulty breathing. Her vital signs are normal except for a low-grade fever (37.8°C). The most likely diagnosis is a viral upper respiratory tract infection (the common cold) or acute viral bronchitis.

2. Decide – Are antibiotics really needed?

• Action: Based on the diagnosis, decide if an antibiotic is indicated. For many common illnesses (like bronchitis, most sore throats, sinusitis), the answer is “no.” Consider if tests (like a culture) are needed to guide this decision.
• Example: Since the diagnosis is a viral infection, antibiotics are not needed. They will not help her recover and will only expose her to potential side effects and contribute to AMR. The decision is for “No Antibiotic Care” with symptomatic treatment.

3. Drug (Medicine) – Which antibiotic to prescribe?

• Action: If an antibiotic is needed, select the most appropriate one. The AWaRe classification guides this: Choose an Access antibiotic first (e.g., amoxicillin) whenever possible. Consider patient-specific factors like known allergies.
• Example (Alternative Scenario): If this same patient had signs of a bacterial infection (e.g., acute otitis media with a bulging eardrum), the chosen drug would be Amoxicillin—an Access antibiotic.

4. Dose – What dose, how many times a day?

• Action: Determine the correct therapeutic dose based on the infection’s severity, the patient’s weight (especially in children), and organ function (e.g., kidney or liver). Avoid under-dosing (ineffective) and over-dosing (toxic).
• Example (for otitis media): For an adult, the dose would be Amoxicillin 500 mg.

5. Delivery – What formulation to use?

• Action: Decide on the route of administration: oral, intravenous (IV), intramuscular (IM), etc. The principle is to use the least invasive, most effective route. For most infections, oral is preferred. If IV treatment is started, plan for an early “step down” to oral as soon as clinically possible.
• Example: For uncomplicated otitis media, the delivery is oral.

6. Duration – For how long?

• Action: Prescribe the shortest effective duration based on evidence. The AWaRe book provides guidance on this (e.g., 5 days for otitis media, 3-5 days for many simple infections). Avoid unnecessarily long courses.
• Example: The prescribed duration for otitis media would be 5 days.

7. Discuss – Inform the patient.

• Action: This is a critical step in patient-centered care. Explain the diagnosis, the expected course of the illness, the rationale for (or against) antibiotics, potential side effects of the medicine, and what to do if symptoms don’t improve.
• Example (in our original “no antibiotic” scenario): “Based on my examination, you have a viral infection, like a strong cold. Antibiotics don’t work against viruses. I recommend rest, fluids, and paracetamol for the fever and pain. Your cough might last for 2-3 weeks. Please return if you develop trouble breathing, a high fever that doesn’t go away, or if you start feeling much worse.”

8. Document – Write it all down.

• Action: Record all the above decisions in the patient’s notes: the diagnosis, the decision on antibiotics (and the reason), the drug, dose, route, duration, and what was discussed with the patient.
• Example: In the medical record: “Dx: Acute viral bronchitis. Decision: No antibiotic indicated. Discussed natural course of illness (cough may persist for weeks) and advised symptomatic management with paracetamol. Advised to return if symptoms worsen. Patient understood.“

---

Application and Relation to Pharmacovigilance

Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem. The “Think D8” principle is not just about AMR stewardship; it is also a powerful front-line pharmacovigilance and patient safety tool.

Here’s how each “D” directly contributes to pharmacovigilance:

• Diagnose & Decide: By ensuring antibiotics are only used when necessary, D1 and D2 drastically reduce the number of patients exposed to the risk of antibiotic-related Adverse Drug Reactions (ADRs) in the first place. This is primary prevention.
• Drug & Dose: Selecting the correct drug (D3) and dose (D4) minimizes the risk of ADRs caused by inappropriate or toxic dosing. For example, avoiding a drug the patient is allergic to prevents hypersensitivity reactions. Correct dosing prevents toxicity (e.g., aminoglycosides and kidney damage).
• Discuss (Crucial for PV): This step is fundamental to active patient involvement in safety monitoring.
  • When a prescriber explains potential side effects (e.g., “This antibiotic can sometimes cause diarrhea; if it becomes severe or watery, contact me”), the patient becomes a partner in monitoring.
  • This empowers the patient to recognize and report potential ADRs early, rather than dismissing them as unrelated. It creates a direct channel for real-world safety feedback.
• Document (The Foundation of PV): Proper documentation (D8) is the cornerstone of traceability and analysis.
  • It creates a clear record that links a specific drug to a patient. If an ADR occurs later, this record is essential for establishing causality.
  • It allows for the audit of prescribing practices. If a certain drug is frequently associated with ADRs, health systems can identify this trend and take action.
  • Accurate documentation is the source data for many national and international ADR reporting systems.

In summary, the “Think D8″ principle embeds the core principles of pharmacovigilance—”first, do no harm” and proactive risk management—directly into the moment of prescription. It ensures that antibiotic use is not only effective for the individual patient but also monitored and documented in a way that contributes to the broader understanding of drug safety for the entire population.